Hadjivassiliou M, GruÈnewald R, Sharrack B, Sanders D, Lobo A, Williamson C, et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain. 2003;126:685–91. https://doi.org/10.1093/brain/awg050.
Abdo WF, van de Warrenburg BPC, Munneke M, van Geel WJA, Bloem BR, Kremer HPH, et al. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Neurology. 2006;67:474–9. https://doi.org/10.1212/01.wnl.0000227891.25592.8c.
CAS Article PubMed Google Scholar
Netravathi M, Sathyaprabha TN, Jayalaxmi K, Datta P, Nirmala M, Pal PK. A comparative study of cardiac dysautonomia in autosomal dominant spinocerebellar ataxias and idiopathic sporadic ataxias. Acta Neurol Scand. 2009;120:204–9. https://doi.org/10.1111/j.1600-0404.2008.01144.x.
CAS Article PubMed Google Scholar
Hadjivassiliou M, Grunewald RA, Shanmugarajah PD, Sarrigiannis PG, Zis P, Skarlatou V, et al. Treatment of primary autoimmune cerebellar ataxia with mycophenolate. The Cerebellum. 2020;19:680–4. https://doi.org/10.1007/s12311-020-01152-4.
CAS Article PubMed Google Scholar
Ariño H, Gresa-Arribas N, Blanco Y, Martínez-Hernández E, Sabater L, Mar Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009–16. https://doi.org/10.1001/jamaneurol.2014.1011.
Article PubMed PubMed Central Google Scholar
Watanabe H, Riku Y, Hara K, Kawabata K, Nakamura T, Ito M, et al. Clinical and imaging features of multiple system atrophy: challenges for an early and clinically definitive diagnosis. J Mov Disord. 2018;11:107–20. https://doi.org/10.14802/jmd.18020.
Article PubMed PubMed Central Google Scholar
Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Parkinsonism Relat Disord. 2013;19:1149–51. https://doi.org/10.1016/j.parkreldis.2013.07.019.
Sillevis Smitt P, Kinoshita A, de Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21–7. https://doi.org/10.1056/NEJM200001063420104.
CAS Article PubMed Google Scholar
Maso WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997;120:1279–300. https://doi.org/10.1093/brain/120.8.1279.
Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med. 1990;322:1844–51. https://doi.org/10.1056/NEJM199006283222604.
CAS Article PubMed Google Scholar
de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71:815–24. https://doi.org/10.1002/ana.23550.
CAS Article PubMed Google Scholar
Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97:839–87. https://doi.org/10.1152/physrev.00010.2016.
CAS Article PubMed PubMed Central Google Scholar
Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20. https://doi.org/10.1212/01.wnl.0000219042.60538.92.
Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, et al. Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia. Neurology. 2017;89:1043–9. https://doi.org/10.1212/WNL.0000000000004311.
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–6. https://doi.org/10.1212/01.wnl.0000324625.00404.15.
CAS Article PubMed PubMed Central Google Scholar
Damato V, Balint B, Kienzler AK, Irani SR. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Disord. 2018;33:1376–89. https://doi.org/10.1002/mds.27446.
Article PubMed PubMed Central Google Scholar
Joubert B, Honnorat J. Nonparaneoplastic autoimmune cerebellar ataxias. Curr Opin Neurol. 2019;32:484–92. https://doi.org/10.1097/wco.0000000000000678.
Narayan RN, McKeon A, Fife TD. Autoimmune vestibulocerebellar syndromes. Semin Neurol. 2020;40:97–115. https://doi.org/10.1055/s-0039-3402061.
Yoshikura N, Kimura A, Fukata M, Fukata Y, Yokoi N, Harada N, et al. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies. J Neuroimmunol. 2018;319:63–7. https://doi.org/10.1016/j.jneuroim.2018.04.001.
CAS Article PubMed Google Scholar
Fuseya K, Kimura A, Yoshikura N, Yamada M, Hayashi Y, Shimohata T. Corticobasal syndrome in a patient with anti-IgLON5 antibodies. Mov Disord Clin Pract. 2020;7:557–9. https://doi.org/10.1002/mdc3.12957.
Article PubMed PubMed Central Google Scholar
Buchhalter JR, Dichter MA. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res Bull. 1991;26:333–8. https://doi.org/10.1016/0361-9230(91)90003-3.
CAS Article PubMed Google Scholar
Hadjivassiliou M, Boscolo S, Tongiorgi E, Grünewald RA, Sharrack B, Sanders DS, et al. Cerebellar ataxia as a possible organ-specific autoimmune disease. Mov Disord. 2008;23:1370–7. https://doi.org/10.1002/mds.22129.
Bürk K, Wick M, Roth G, Decker P, Voltz R. Antineuronal antibodies in sporadic late-onset cerebellar ataxia. J Neurol. 2010;257:59–62. https://doi.org/10.1007/s00415-009-5262-8.
CAS Article PubMed Google Scholar
Sivera R, Martín N, Boscá I, Sevilla T, Muelas N, Azorín I, et al. Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia. J Neurol. 2012;259:851–4. https://doi.org/10.1007/s00415-011-6266-8.
CAS Article PubMed Google Scholar
Hadjivassiliou M. Primary autoimmune cerebellar ataxia (PACA). Adv Clin Neurosci Rehabil. 2010;9:8–11.
Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, et al. Diagnostic criteria for primary autoimmune cerebellar ataxia -guidelines from an international task force on immune-mediated cerebellar ataxias. Cerebellum. 2020;9:605–10. https://doi.org/10.1007/s12311-020-01132-8.
Hadjivassiliou M, Wild G, Shanmugarajah P, Grünewald RA, Akil M. Indirect immunofluorescent assay as an aid in the diagnosis of suspected immune mediated ataxias. Cerebellum Ataxias. 2021;8:6. https://doi.org/10.1186/s40673-021-00129-1.
Article PubMed PubMed Central Google Scholar
Buckley C, Oger J, Clover L, Tüzün E, Carpenter K, Psych D, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73–8. https://doi.org/10.1002/ana.1097.
CAS Article PubMed Google Scholar
Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764–77. https://doi.org/10.1093/brain/awh526.
Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378:840–51. https://doi.org/10.1056/nejmra1708712.
CAS Article PubMed Google Scholar
Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog EJ, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72:1304–12. https://doi.org/10.1001/jamaneurol.2015.2378.
Jia Y, Li M, Li D, Zhang M, Wang H, Jiao L, et al. Immune-mediated cerebellar ataxia associated with neuronal surface antibodies. Front Immunol. 2022;13:813926. https://doi.org/10.3389/fimmu.2022.813926.
CAS Article PubMed PubMed Central Google Scholar
Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ. Microtubule-associated protein 1B: Novel paraneoplastic biomarker. Ann Neurol. 2017;81:266–77. https://doi.org/10.1002/ana.24872.
CAS Article PubMed Google Scholar
Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, et al. Autoimmune Septin-5 cerebellar ataxia. Neurol Neuroimmunol Neuroinflamm. 2018;5:e474. https://doi.org/10.1212/nxi.0000000000000474.
Article PubMed PubMed Central Google Scholar
Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, et al. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology. 2019;93:e954–63. https://doi.org/10.1212/wnl.0000000000008061.
Article PubMed PubMed Central Google Scholar
Maudes E, Landa J, Muñoz-Lopetegi A, Armangue T, Alba M, Saiz A, et al. Clinical significance of Kelch-like protein 11 antibodies. Neurol Neuroimmunol Neuroinflamm. 2020;7:e666. https://doi.org/10.1212/nxi.0000000000000666.
Article PubMed PubMed Central Google Scholar
Höftberger R, Sabater L, Ortega A, Dalmau J, Graus F. Patient with homer-3 antibodies and cerebellitis. JAMA Neurol. 2013;70:506–9. https://doi.org/10.1001/jamaneurol.2013.1955.
留言 (0)